OBX — Obsidian Therapeutics Share News
0.000.00%
Last trade - 00:00- $861.11m
- $861.11m
U.S. STOCKS ON THE MOVE-Air Transport Services Group, Dillard's, Precigen
Galera Therapeutics hits record low after FDA declines to approve inflammation drug
U.S. STOCKS ON THE MOVE-Capri Holdings, Amyris, gold miners
U.S. STOCKS ON THE MOVE-YETI Holdings, Catalyst Pharma, ZimVie
U.S. STOCKS ON THE MOVE-Capri, Digital World, Lyft
Galera Therapeutics sinks after FDA declines to approve inflammation drug
U.S. RESEARCH ROUNDUP-Penn Entertainment, Roblox, Sonendo
Galera shares tank after US FDA declines to approve inflammation disease drug
Galera Therapeutics Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Galera Therapeutics - On May 30, Filed A Lawsuit Against Alira Health Clinical, Llc And Iqvia Biotech, Llc Alleging Breach Of Contract And Negligence
Brief: Galera Announces FDA Orphan Drug Designation Granted To Rucosopasem For Pancreatic Cancer
Galera Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Galera Reports Q1 2023 Financial Results And Recent Corporate Updates
H.C. Wainwright cuts Galera's PT after stock sale
Brief: Galera To Present Supplemental Analysis Of Phase 3 Trial At European Congress On Head And Neck Oncology
Galera Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Galera Reports Fourth Quarter And 2022 Financial Results
Galera Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Galera Therapeutics Inc Files For Offering Of Up To 14.32 Million Shares Of Common Stock - SEC Filing